ETM-ANN Approach Application for Thiobenzamide and Quinolizidine Derivatives
dc.authorid | 0000-0002-0411-9258 | |
dc.authorid | 0000-0002-9352-7332 | |
dc.authorid | 0000-0002-8773-2700 | |
dc.contributor.author | Saracoglu, M. | |
dc.contributor.author | Kandemirli, F. | |
dc.contributor.author | Kovalishyn, V. | |
dc.contributor.author | Arslan, T. | |
dc.contributor.author | Ebenso, E. E. | |
dc.date.accessioned | 2019-08-01T13:38:39Z | |
dc.date.available | 2019-08-01T13:38:39Z | |
dc.date.issued | 2010 | |
dc.department | Niğde ÖHÜ | |
dc.description.abstract | The structure anti-influenza activity relationships of thiobenzamide and quinolizidine derivatives, being influenza fusion inhibitors, have been investigated using the electronic-topological method (ETM) and artificial neural network (ANN) method. Molecular fragments specific for active compounds and breaks of activity were calculated for influenza fusion inhibitors by applying the ETM. QSAR descriptors such as molecular weight, E(HOMO), E(LUMO), Delta E, chemical potential, softness, electrophilicity index, dipole moment, and so forth were calculated, and it was found to give good statistical qualities (classified correctly 92%, or 48 compounds from 52 in training set, and 69% or 9 compounds from 13 in the external test set). By using multiple linear regression, several QSAR models were performed with the help of calculated descriptors and the compounds activity data. Among the obtained QSAR models, statistically the most significant one is the one of skeleton 1 with R(2) = 0.999. | |
dc.description.sponsorship | Kocaeli University | |
dc.description.sponsorship | This work was financially supported by the Research Fund of Kocaeli University and we thank TUBITAK-ULAKBIM TR-GRID for calculation of molecules. The authors would like to express their sincere gratitude to Professor A. Dimoglo for the fruitful discussions of the results of this study and valuable help in preparing this paper for publishing. | |
dc.identifier.doi | 10.1155/2010/693031 | |
dc.identifier.issn | 1110-7243 | |
dc.identifier.pmid | 20871848 | |
dc.identifier.scopus | 2-s2.0-77957850128 | |
dc.identifier.scopusquality | N/A | |
dc.identifier.uri | https://dx.doi.org/10.1155/2010/693031 | |
dc.identifier.uri | https://hdl.handle.net/11480/4958 | |
dc.identifier.wos | WOS:000283171300001 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | [0-Belirlenecek] | |
dc.language.iso | en | |
dc.publisher | HINDAWI PUBLISHING CORPORATION | |
dc.relation.ispartof | JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | ETM-ANN Approach Application for Thiobenzamide and Quinolizidine Derivatives | |
dc.type | Article |